Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Assessing Safety and Tolerability of a DNA Vaccine With a DNA Encoded Immunostimulator , Administered by Particle Mediated Epidermal Delivery Using the PowderMed ND10 Delivery System in HSV-2 Seronegative Healthy Volunteers

NCT00310271 is registered in ClinicalTrials.gov with PowderMed as lead sponsor.

NCT NCT00310271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00310271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Assessing Safety and Tolerability of a DNA Vaccine With a DNA Encoded Immunostimulator , Administered by Particle Mediated Epidermal Delivery Using the PowderMed ND10 Delivery System in HSV-2 Seronegative Healthy Volunteers
Lead sponsor
PowderMed
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2006
Completion date
December 31, 2006
Enrollment
42
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hsv-2